Clinical Trials Directory

Trials / Unknown

UnknownNCT05558930

Cerebellar iTBS in Patients With Disorders of Consciousness

MRI-navigated Cerebellar Intermittent Theta-Burst Stimulation(iTBS)in Patients With Disorders of Consciousness

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Previous studies showed the excitatory effect of cerebellar transcranial magnetic stimulation(TMS) on motor cortex.Investigator evaluate the effects of bilateral cerebellar TMS on Coma Recovery Scale-Revised (CRS-R) scores in patients with disorders of consciousness(DOC) in a randomized, double-blinded, sham-controlled, crossover experimental design.

Detailed description

Patients with disorders of consciousness(DOC) resulting from severe brain injury greatly burden caregivers, health care facilities, and society. However, there is no definitively effective treatment for patients with DOC. Previous studies showed the excitatory effect of cerebellar transcranial magnetic stimulation(TMS) on motor cortex through the dentato-rubro-thalamic tract. Investigators aim to validate the effect of 5 consecutive sessions of intermittent theta-burst stimulation(iTBS) of bilateral cerebellar on level of consciousness of patients in vegetative state(VS)/unresponsive awakening state(UWS)or minimally conscious (MCS) state in a randomized, double-blinded, sham-controlled, crossover study. TMS is a non-invasive and safe neural regulatory approach that is widely used in depression, schizophrenia, stroke, and Parkinson's disease.

Conditions

Interventions

TypeNameDescription
DEVICEiTBS stimulationstandard iTBS burst pattern:3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals. 600 pulses on both side of cerebellar with an interval of 5 minutes.
DEVICEsham stimulationParticipants receive a sound stimulation with the same pattern with iTBS stimulation,but without magnetic field

Timeline

Start date
2022-04-29
Primary completion
2023-04-01
Completion
2023-10-01
First posted
2022-09-28
Last updated
2022-09-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05558930. Inclusion in this directory is not an endorsement.